Orthopedic liver transplantation in high-risk patients

Transplantation

Volumn 65, Issue 4, 1998, Pages 499-504

  Gayowski, Timothy ^a   Marino, Ignazio R ^b   Singh, Nina ^b   Doyle, Howard ^b   Wagener, Marilyn ^b   Fung, John J ^b   Starzl, Thomas E ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; GRAFT SURVIVAL; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SOLDIER; UNITED STATES; ANALYSIS OF VARIANCE; CLASSIFICATION; LIVER DISEASE; MIDDLE AGED; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AGED; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MILITARY PERSONNEL; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS; UNITED STATES;

EID: 0032570347     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802270-00008     Document Type: Article

References (26)

1. United Network for Organ Sharing. 1996 Annual report: OPTN and scientific registry of transplant recipients; transplant data: 1988-1995. Richmond, VA: UNOS.
2. Eghtesad B, Bronsther O, Irish W, et al. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994; 20: 565.
3. Muto P, Freeman RB, Hang CE, Lu A, Rohrer R. Liver transplant candidate stratification systems, implications for third party payors and organ allocation. Transplantation 1994; 57(2): 306.
4. Delmonico FL, Jenkins RL, Freeman R, et al. The high-risk liver allograft recipient: should allocation policy consider outcome? Arch Surg 1992; 127: 579.
5. Garrison RM, Bentley FR, Raque GH, et al. There is an answer to the shortage of organ donors. Surg Gynecol Obstet 1991; 173(5): 391.
6. Gortmaker SL, Beasly CL, Brigham LE, et al. Organ donor potential and performance: size and nature of the organ donor shortfall. Crit Care Med 1996; 24(3): 432.
7. Marino IR, Doyle HR, Aldrighetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22(6): 1754.
8. Shaw BW Jr, Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985; 5: 385.
9. Shaw BW Jr, Wood RP, Stratta RJ, Pillen TJ, Lanquist M. Stratifying the causes of death in liver transplant recipients. Arch Surg 1989; 124: 895.
10. Baliga P, Merion RM, Turcotte JG, et al. Pre-operative risk factor assessment in liver transplantation. Surgery 1992; 112: 704.
11. Doyle HR, Marino IR, Jabbour N, et a. Early death or retransplantation in adults after orthotopic liver transplantation: can outcome be predicted? Transplantation 1994; 57: 1028.
12. Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel D. Prognostic value of pre-operatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986; 6(5): 922.
13. Eckhoff DE, Pirsch JD, D'Alessandro AM, et al. Pretransplant status and patient survival following liver transplantation. Transplantation 1995; 60: 920.
14. Gayowski T, Marino IR, Doyle HR, et al. Primary liver transplantation in US veterans under FK506 immunosuppression: a prospective trial. Hepatology 1995; 22: 420A.
15. Bronsther O, Fung JJ, Tzakis A, Van Thiel D, Starzl TE. Priorization and organ distribution for liver transplantation. JAMA 1994; 271: 440.
16. Gayowski T, Marino IR, Doyle HR, et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996; 60: 333.
17. Mieles LA, Fung JJ, Yokoyama I, et al. Liver transplantation of American veterans under FK506 immunosuppression: a preliminary report. Transplant Proc 1991; 23(6): 3016.
18. Singh M, Gayowski T, Wagener MM, Yu VL. Infectious complications in liver transplant recipients on tacrolimus: prospective analysis of 88 consecutive liver transplants. Transplantation 1994; 58(7): 774.
19. Marino IR, Morelli F, Doria C, et al. Pre-operative assessment of risk in liver transplantation: a multivariable analysis in 2376 cases in the UW era. Transplant Proc 1997; 29(V2): 454.
20. Blue Cross and Blue Shield Association. Liver transplant network survey: Chicago: Blue Cross and Blue Shield Association, October, 1990.
21. Brown RS, Lamberdero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996; 62(2): 1788.
22. Doyle HR, Marino IR, Marelli F, et al. Assessing risk in liver transplantation: special reference of a positive cytotoxic crossmatch. Ann Surg 1996; 224(2): 168.
23. Takaya S, Bronsther O, Iwaki Y, et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch cloning. Transplantation 1992; 53: 400.
24. Katz SM, Kimball RM, Ozaki C, et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients. Transplantation 1994; 58: 786.
25. Singh M, Gayowski T, Wagener MM, Marino IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996; 61(3): 402.
26. Cacciarelli TV, Martinez OM, Gish RG, Villaneuva JC, Kraus SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and post-treatment with interferon alpha. Hepatology 1996; 24(1): 6.